Home > Compound List > Product Information
Nomifensine_Molecular_structure_CAS_24526-64-5)
Click picture or here to close

Nomifensine

Catalog No. DB04821 Name DrugBank
CAS Number 24526-64-5 Website http://www.ualberta.ca/
M. F. C16H18N2 Telephone (780) 492-3111
M. W. 238.32752 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 4365

SYNONYMS

IUPAC name
2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine
IUPAC Traditional name
nomifensine
Brand Name
Linamiphen
Nomifenison
Merital
Synonyms
Nomifensinum [inn-latin]
(+)-nomiphensine
2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine
8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline
(+-)-nomifensin
Nomifensin
(+)-nomifensine
(+-)-nomifensine
(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine
8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin
8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
Nomifensina [inn-spanish]
Nomifensine maleate
Nomifensine hydrogen maleate

DATABASE IDS

PubChem SID 46505804
CAS Number 24526-64-5
PubChem CID 4528

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups withdrawn
Description Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia. The approved application holder removed Merital capsules from the market on January 23, 1986. FDA published a notice of its determination that Merital capsules were removed from the market for safety reasons (see the Federal Register of June 17, 1986 (51 FR 21981)). Approval of the NDA for Merital capsules was withdrawn on March 20, 1992 (see the Federal Register of March 20, 1992 (57 FR 9729)). Also withdrawn from the Canadian and UK markets.
Pharmacology Nomifensine is a dopamine reuptake inhibitor test-marketed in the United States by Hoechst AG (now Novartis) that increases the amount of synaptic dopamine available to receptors by blocking dopamine's re-uptake transporter. Nomifensine is now mainly used in scientific research, particularly in studies involving dopamine release in response to addiction.
Toxicity A likely cause of nomifensine toxicity is the aromatic amine group, as compounds containing this chemical substructure are notorious for producing toxic metabolites.
Affected Organisms
Humans and other mammals
External Links
Wikipedia

REFERENCES